BioCentury
ARTICLE | Finance

Royalties don't dilute

BB Biotech boosts Intercell with EUR25M in equity and debt with royalty twist

May 14, 2012 7:00 AM UTC

Swiss biotech investor BB Biotech AG(SIX:BION; Xetra:BBZA) expects Intercell AG (VSE:ICLL; OTCQX:INRLY) to reach profitability with last week's infusion of €25 million ($32.5 million) in cash.

The financings from BB Biotech included €20 million in debt and €5 million in a private placement of about 2 million Intercell shares...